Fluzopalil in Combination With Anlotinib for Extensive Small-cell Lung Cancer

Clinical trial NCT04933175 · UNKNOWN

Trial details

NCT number: NCT04933175
Sponsor: Liu Zhenhua
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive Stage Small Cell Lung Cancer

Start date: 2021-06-01
Primary completion: 2022-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.